Wajeeha Razaq to BRCA1 Protein
This is a "connection" page, showing publications Wajeeha Razaq has written about BRCA1 Protein.
Connection Strength
0.051
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early?breast cancer. Ann Oncol. 2022 Dec; 33(12):1250-1268.
Score: 0.051